02/12/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/12/2020. This web page, updated on February 12, 2020, provides interim guidance for healthcare professionals regarding the 2019 novel coronavirus in three sections: Criteria to Guide Evaluation of Patients Under Investigation (PUI) for 2019-nCoV; Recommendations for Reporting, Testing, and Specimen Collection; and Interim Healthcare Infection Prevention and Control Recommendations for Patients Under Investigation for 2019-nCoV. (Text)
02/12/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/12/2020. This interim guidance, updated on February 12, 2020, is for staff at local and state health departments, infection prevention and control professionals, healthcare providers, and healthcare workers who are coordinating the home care and isolation of people who are confirmed to have, or being evaluated for 2019 novel coronavirus (2019-nCoV) infection. It does not apply to patients in healthcare settings. (Text)
02/10/2020 12:00 AM EST
Source: Hudson Institute. Published: 2/10/2020. This one-hour, 38-minute panel discussion, cosponsored by the Bipartisan Commission on Biodefense, focuses on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. Panel participants offer their perspectives on the role of the federal government in managing the crisis, the lack of transparency by the Communist Chinese Government, implications for U.S national security, and how the country can better prepare for when the next pandemic strikes. (Video or Multimedia)
02/09/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/9/2020. This web page for healthcare professionals provides answers to frequently asked questions about the 2019 novel coronavirus (2019-nCoV). Topics includes the clinical features of 2019-nCoV infection, who is at risk, which body fluids can spread infection, how healthcare personnel should protect themselves when evaluating a patient who may have 2019-nCoV infection, and how to treat a 2019-nCoV infection. (Text)
02/08/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/8/2020. This web page, updated on February 8, 2020, provides information about the outbreak caused by a novel (new) coronavirus first identified in Wuhan, China, under these topics: Situation Summary; What You Need to Know about 2019-nCoV; Information for Travelers; Information for Healthcare Professionals; Information for Laboratories; Information for Public Health Professionals; Information for Businesses; Risk Assessment; and News on 2019-nCoV. (Text)
02/08/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/8/2020. This web page offers guidance on how to optimize supplies of N95 filtering facepiece respirators (commonly called “N95 respirators”) in healthcare settings in the face of potential ongoing 2019 novel coronavirus (2019-nCoV) transmission in the United States. The recommendations are intended for use by professionals who manage respiratory protection programs, occupational health services, and infection prevention programs in healthcare institutions to protect healthcare personnel from job-related risks of exposure to infectious respiratory illnesses. Topics are Engineering Controls; Administrative Controls; and Personal Protective Equipment and Respiratory Protection. (Text)
02/08/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/8/2020. This fact sheet is intended to address frequently asked questions about respirators and their use. Topics include wearing a respirator in public, the N95 filtering facepiece respirator (FFR), the Surgical N95 respirator and who needs to wear it, and a N95 respirator with an exhalation valve. (Text)
02/06/2020 12:00 AM EST
Source: Henry J. Kaiser Family Foundation. Published: 2/6/2020. This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map showing which countries have cases and deaths. It should be noted that the World Health Organization reported case numbers are conservative, and likely represent an undercount of the true number of coronavirus cases, especially in China. This tracker will be updated regularly, as new situation reports are released. (Text)
02/02/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/2/2020. Health care providers should contact their local/state health department immediately to notify them of patients with fever and lower respiratory illness who traveled to Wuhan, China within 14 days of symptom onset. This web page, updated on February 2, 2020, provides information about general guidelines, serum, and shipping related to patients under investigation for 2019 novel corona virus. (Text)
02/02/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/2/2020. This web page, updated on February 2, 2020, provides general and specific biosafety guidelines for handling 2019 novel coronavirus (2019-nCoV) specimens, as well as information about clinical laboratory testing; packing, shipping, and transport; and related resources. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible 2019-nCoV infection. (Text)
02/01/2020 12:00 AM EST
Source: Johns Hopkins University. Published: 2/2020. This map visualizes where cases of the 2019 novel coronavirus (2019-nCoV) are worldwide. It provides the latest figures for the number of confirmed cases, cases by country or region, and deaths. (Text)
02/01/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 2/2020. This 10-page document provides guidance on the application of non-pharmaceutical countermeasures to minimize the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic. (PDF)
02/01/2020 12:00 AM EST
Source: U.S. Department of Health and Human Services (HHS). Published: 2/2020. In light of the 2019 novel coronavirus (2019-nCoV) outbreak, the Office for Civil Rights at the U.S. Department of Health and Human Services is providing this four-page bulletin to ensure that Health Insurance Portability and Accountability Act (HIPAA) covered entities and their business associates are aware of the ways that patient information may be shared under the HIPAA Privacy Rule in an outbreak of infectious disease or other emergency situation, and to serve as a reminder that the protections of the Privacy Rule are not set aside during an emergency. (PDF)
02/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/2020. To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to Ebola virus disease, acquire Ebola virus disease during pregnancy or breastfeeding, or survive Ebola virus disease with ongoing pregnancies. The guidelines in this 52-page document are the first to provide such recommendations. (PDF)
02/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/2020. This web page provides links to World Health Organization novel coronavirus (2019-nCoV) technical guidance in these categories: Country Readiness; Patient Management; Risk Communication and Community Engagement; Surveillance and Case Definitions; Infection Prevention and Control; Disease Commodity Package; Laboratory Guidance; Early Investigations; and Reduction of Transmission from Animals to Humans. (Text)
01/30/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/30/2020. This web page provides answers to frequently asked questions about the 2019 Novel Coronavirus, or 2019-nCoV. Topics cover Disease Basics, Prevention, Medical Information, Public Health Response and Current Situation, Travel, and 2019-nCoV and Animals. It also provides links to additional information on each topic. (Text)
.png)
No hay comentarios:
Publicar un comentario